CIM
BSX icon

CIM Investment Management’s Boston Scientific BSX Stock Holding History

CIM Investment Management’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$743K Sell
11,833
-57
-0.5% -$4.56K 0.2% 88
2025
Q4 		$1.13M Hold
11,890
– – 0.3% 56
2025
Q3 		$1.16M Sell
11,890
-12,202
-51% -$1.26M 0.32% 55
2025
Q2 		$2.37M Buy
24,092
+12,023
+100% +$1.22M 0.45% 41
2025
Q1 		$1.22M Sell
12,069
-9
-0.1% -$906 0.28% 46
2024
Q4 		$1.08M Buy
12,078
+55
+0.5% +$4.84K 0.32% 53
2024
Q3 		$1.01M Sell
12,023
-215
-2% -$16.9K 0.3% 59
2024
Q2 		$942K Sell
12,238
-71
-0.6% -$5.2K 0.29% 64
2024
Q1 		$843K Hold
12,309
– – 0.25% 75
2023
Q4 		$712K Hold
12,309
– – 0.23% 90
2023
Q3 		$650K Sell
12,309
-298
-2% -$15.6K 0.24% 91
2023
Q2 		$682K Buy
12,607
+31
+0.2% +$1.62K 0.23% 93
2023
Q1 		$629K Buy
12,576
+616
+5% +$29K 0.23% 94
2022
Q4 		$553K Sell
11,960
-341
-3% -$14.8K 0.22% 101
2022
Q3 		$476K Hold
12,301
– – 0.21% 105
2022
Q2 		$458K Sell
12,301
-69
-0.6% -$2.81K 0.19% 109
2022
Q1 		$548K Sell
12,370
-14
-0.1% -$607 0.19% 111
2021
Q4 		$526K Sell
12,384
-239
-2% -$10K 0.16% 138
2021
Q3 		$548K Sell
12,623
-76
-0.6% -$3.36K 0.17% 125
2021
Q2 		$543K Sell
12,699
-70
-0.5% -$2.94K 0.17% 129
2021
Q1 		$494K Sell
12,769
-496
-4% -$18.8K 0.16% 139
2020
Q4 		$477K Sell
13,265
-219
-2% -$7.89K 0.15% 132
2020
Q3 		$515K Sell
13,484
-147
-1% -$5.67K 0.2% 106
2020
Q2 		$479K Buy
+13,631
New +$491K 0.19% 107

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

CIM Investment Management's BSX Position: Q1 2026 in Review

CIM Investment Management reduced its Boston Scientific (BSX) stake by 0.48% in Q1 2026, selling an estimated $4.56K and leaving 11,833 shares worth $743K. The position accounts for 0.2% of the portfolio, ranked #88.

CIM Investment Management first reported a position in BSX in Q2 2020 and has held it in 24 quarters since. The position peaked at $2.37M in Q2 2025. 1,676 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

  • CIM Investment Management held 11,833 shares of Boston Scientific worth $743K as of Q1 2026.
  • CIM Investment Management sold 57 Boston Scientific shares in Q1 2026, an estimated $4.56K.
  • Boston Scientific made up 0.2% of CIM Investment Management's portfolio in Q1 2026, its #88 holding.
  • CIM Investment Management first reported a position in Boston Scientific in Q2 2020 and has held it in 24 quarters since.
  • CIM Investment Management's Boston Scientific position peaked at $2.37M in Q2 2025.
  • 1,676 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on CIM Investment Management's 13F filing for Q1 2026, filed 19 May 2026.